"Adding cyclosporine to an antiretroviral (ARV) regimen during the first few weeks or months of HIV infection does not offer additional benefit in terms of virus suppression, CD4 cell increases or reduced immune activation. That’s the verdict, according to a study published March 17 in The Journal of Infectious Diseases."
Read more in POZ, March 18, 2010.
0 comments:
Post a Comment